Published in J Virol on July 01, 1977
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. J Virol (1989) 4.60
Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping. J Virol (1984) 1.90
Transformation of rat cells by fusion-infection with Rous sarcoma virus. J Virol (1980) 1.60
Some biological properties of two new avian sarcoma viruses. J Virol (1981) 1.57
A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc Natl Acad Sci U S A (1987) 1.51
Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element. Proc Natl Acad Sci U S A (1995) 1.16
Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells. J Virol (1990) 1.13
Transfection by DNAs of avian erythroblastosis virus and avian myelocytomatosis virus strain MC29. J Virol (1980) 1.10
Avian sarcoma virus-transformed quail clones defective in the production of focus-forming virus. J Virol (1979) 1.07
Bacterial fusion assayed by a prophage complementation test. J Bacteriol (1979) 1.07
Bovine colostrum supports the serum-free proliferation of epithelial cells but not of fibroblasts in long-term culture. J Cell Biol (1980) 0.93
Expression of integrated Rous sarcoma viruses: DNA rearrangements 5' to the provirus are common in transformed rat cells but not seen in infected but untransformed cells. EMBO J (1986) 0.90
Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85. J Virol (1991) 0.88
Arrangement of integrated avian sarcoma virus DNA sequences within the cellular genomes of transformed and revertant mammalian cells. J Virol (1980) 0.88
Spontaneous conversion of nontransformed avian sarcoma virus-infected rat cells to the transformed phenotype. J Virol (1980) 0.86
Serum-free growth of normal and transformed fibroblasts in milk: differential requirements for fibronectin. J Cell Biol (1981) 0.86
Transformation of rat cerebral endothelial cells by Rous sarcoma virus. J Cell Biol (1983) 0.84
Cell fusion for genetic analysis of two nonconditional Rous sarcoma virus replication mutants. J Virol (1979) 0.80
Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation. J Virol (2014) 0.77
Target antigens for antibodies and complement at the cell surface of RSV-transformed fibroblasts. Immunology (1980) 0.76
Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet (1976) 5.05
Production of mammalian somatic cell hybrids by means of polyethylene glycol treatment. Somatic Cell Genet (1975) 4.74
Integration of deoxyribonucleic acid specific for Rous sarcoma virus after infection of permissive and nonpermissive hosts. Proc Natl Acad Sci U S A (1973) 4.19
Carcinogenesis by RNA sarcoma viruses. XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses. Virology (1970) 3.90
Characteristics of two new avian tumor virus subgroups. Virology (1969) 3.81
ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS. Proc Natl Acad Sci U S A (1964) 3.77
Appearance of virus-specific DNA in mammalian cells following transformation by Rous sarcoma virus. J Mol Biol (1973) 3.21
Patterns of viral interference in the avian leukosis and sarcoma complex. Virology (1966) 3.12
Reversion in Hamster Cells Transformed by Rous Sarcoma Virus. Science (1965) 2.68
Polyethylene glycol-induced mammalian cell hybridization: effect of polyethylene glycol molecular weight and concentration. Somatic Cell Genet (1976) 2.46
RNA of replication-defective strains of Rous sarcoma virus. Proc Natl Acad Sci U S A (1975) 2.37
Virogenic nontransformed cells isolated following infection of normal rat kidney cells with B77 strain Rous sarcoma virus. Cell (1974) 1.62
Ribonuclease-sensitive deoxyribonucleic acid polymerase activity in uninfected rat cells and rat cells infected with Rous sarcoma virus. J Virol (1971) 1.54
Independent regulation of endogenous and exogenous avian RNA tumor virus genes. Proc Natl Acad Sci U S A (1976) 1.33
MALIGNIZATION OF RAT EMBRYONIC CELLS BY ROUS SARCOMA VIRUS IN VITRO. Folia Biol (Praha) (1963) 1.23
Rescue of Rous sarcoma virus from virogenic mammalian cells associated with chicken cells and treated with Sendai virus. J Gen Virol (1969) 1.15
The persistence and expression of virus-specific DNA in revertants of Rous sarcoma virus-transformed BHK-21 cells. Virology (1974) 1.10
Common tumor-specific surface antigens on cells of different species transformed by avian RNA tumor viruses. Virology (1972) 1.10
Virus envelope markers in mammalian tropism of avian RNA tumor viruses. J Virol (1975) 1.09
Reversion and induction of Rous sarcoma virus expression in virus-transformed baby hamster kidney cells. Virology (1974) 1.03
Characteristics of tumors induced in mammals, especially rodents, by viruses of the avian leukosis sarcoma group. Adv Virus Res (1972) 1.00
Comparative study of RSV rescue from RSV-transformed mammalian cells. Int J Cancer (1971) 0.99
A full expression of the genome of Rous sarcoma virus in heterokaryons formed after fusion of virogenic mammalian cells and chicken fibroblasts. J Gen Virol (1970) 0.96
Rescue of rous sarcoma virus from rous sarcoma virus-transformed mammalian cells. J Virol (1972) 0.94
Interaction of Rous sarcoma virus with rat embryo fibroblasts of inbred Lewis strain in vitro. Folia Biol (Praha) (1968) 0.92
Cytology and growth characteristics of human tumour astrocytes transformed by Rous sarcoma virus. J Cell Sci (1969) 0.88
Persistence of Rous sarcoma virus in transformed nonpermissive cells: relationship between virus induction by association with permissive cells and gs antigen content of transformed cells. Virology (1971) 0.85
Interaction of Chinese hamster embryonic cells with the helper-dependent Rous sarcoma virus. Folia Biol (Praha) (1974) 0.81
Persistence of Rous sarcoma virus in transformed non-permissive cells: characteristics of virus induction following Sendai virus-mediated fusion with permissive cells. Int J Cancer (1973) 0.81
Persistence of Rous sarcoma virus in transformed non-permissive cells: mechanism of virus induction by association with permissive cells in the absence of Sendai virus. Int J Cancer (1972) 0.80
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science (1985) 10.97
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
A DNA-depenent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature (1970) 3.31
Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell (1999) 2.82
Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell (1987) 2.76
Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature (1988) 2.66
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial. J Infect Dis (1995) 2.23
Expression and function of chicken integrin beta 1 subunit and its cytoplasmic domain mutants in mouse NIH 3T3 cells. J Cell Biol (1990) 2.16
Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine. Nature (1970) 2.02
Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J Virol (1992) 1.94
Transformation of chondroblasts by Rous sarcoma virus and synthesis of the sulfated proteoglycan matrix. Cell (1977) 1.86
Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria. Virology (1986) 1.81
Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus. Virology (1977) 1.67
Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine (1997) 1.63
Virogenic nontransformed cells isolated following infection of normal rat kidney cells with B77 strain Rous sarcoma virus. Cell (1974) 1.62
Differential effects of transforming avian RNA tumor viruses on avian macrophages. Proc Natl Acad Sci U S A (1981) 1.60
Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res Hum Retroviruses (1990) 1.60
Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res (1985) 1.52
Transformation of chicken embryo retinal melanoblasts by a temperature-sensitive mutant of Rous sarcoma virus. Cell (1977) 1.50
Developmental regulation of c-myb in normal myeloid progenitor cells. Proc Natl Acad Sci U S A (1985) 1.49
Force required to break alpha5beta1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J Biol Chem (1998) 1.46
Regulation of the synthesis of extracellular matrix components in chondroblasts transformed by a temperature-sensitive mutant of Rous sarcoma virus. Cell (1982) 1.38
Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. Proc Natl Acad Sci U S A (1991) 1.37
Replicating, differentiated macrophages can serve as in vitro targets for transformation by avian myeloblastosis virus. J Virol (1981) 1.34
Quantification of cell adhesion using a spinning disc device and application to surface-reactive materials. Biomaterials (1997) 1.29
Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses. J Gen Virol (1987) 1.26
Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest (1989) 1.25
Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein. Proc Natl Acad Sci U S A (1990) 1.21
Integrin-fibronectin interactions at the cell-material interface: initial integrin binding and signaling. Biomaterials (1999) 1.21
Expression and processing of biologically active fibroblast growth factors in the yeast Saccharomyces cerevisiae. J Biol Chem (1988) 1.21
Efficient retroviral-mediated gene transfer into human B lymphoblastoid cells expressing mouse ecotropic viral receptor. Nucleic Acids Res (1992) 1.16
Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. Vaccine (1987) 1.15
Two-stage activation for alpha5beta1 integrin binding to surface-adsorbed fibronectin. J Biol Chem (1998) 1.14
myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts. Mol Cell Biol (1985) 1.11
Effect of src infection on long-term marrow cultures: increased self-renewal of hemopoietic progenitor cells without leukemia. Cell (1984) 1.11
Continuous in vitro generation of multipotential stem cell clones from src-infected cultures. Nature (1984) 1.10
The persistence and expression of virus-specific DNA in revertants of Rous sarcoma virus-transformed BHK-21 cells. Virology (1974) 1.10
Virus envelope markers in mammalian tropism of avian RNA tumor viruses. J Virol (1975) 1.09
Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.08
Effect of surface reaction stage on fibronectin-mediated adhesion of osteoblast-like cells to bioactive glass. J Biomed Mater Res (1998) 1.06
Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp Cell Res (1993) 1.06
Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur J Immunol (1994) 1.04
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. AIDS (1995) 1.03
Phenotypic mixing between vesicular stomatitis virus and avian RNA tumor viruses. Cold Spring Harb Symp Quant Biol (1975) 1.03
Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes. J Bone Miner Res (1997) 1.03
Reversion and induction of Rous sarcoma virus expression in virus-transformed baby hamster kidney cells. Virology (1974) 1.03
Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus. J Virol (1989) 1.02
Chemical synthesis and expression in yeast of a gene encoding connective tissue activating peptide-III. A novel approach for the facile assembly of a gene encoding a human platelet-derived mitogen. J Biol Chem (1986) 1.02
Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation. Mol Cell Biol (1985) 1.01
Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain. Proc Natl Acad Sci U S A (1991) 1.01
Cellular partitioning of beta-1 integrins and their phosphorylated forms is altered after transformation by Rous sarcoma virus or treatment with cytochalasin D. Cell Regul (1991) 1.00
Altered cell spreading in cytochalasin B: a possible role for intermediate filaments. Mol Cell Biol (1983) 0.99
Characterization of recombinant human epidermal growth factor produced in yeast. Biochemistry (1988) 0.99
Progenitor-cell populations can be infected by RNA tumor viruses, but transformation is dependent on the expression of specific differentiated functions. Cold Spring Harb Symp Quant Biol (1980) 0.97
Developmental expression and molecular cloning of REMP, a novel retinal epithelial membrane protein. Exp Cell Res (1995) 0.97
Target cells for avian myeloblastosis virus in embryonic yolk sac and relationship of cell differentiation to cell transformation. J Virol (1984) 0.96
Animal virus pseudotypes. Prog Med Virol (1979) 0.96
N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae. J Virol (1989) 0.96
Immunological characterization of the major chick cartilage proteoglycan and its intracellular localization in cultured chondroblasts: a comparison with Type II procollagen. J Cell Biol (1983) 0.95
Evaluation of integrin molecules involved in substrate adhesion. Cell Adhes Commun (1993) 0.94
Selective effect of Rous sarcoma virus src gene expression on contractile protein synthesis in chick embryo myotubes. Cancer Res (1983) 0.92
Alpha 5 integrin is a critical component of adhesion plaques in myogenesis. Dev Biol (1993) 0.92
Development of 'revertant' myotubes in cultures of Rous sarcoma virus transformed avian myogenic cells. Differentiation (1983) 0.91
Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals. Clin Immunol Immunopathol (1991) 0.89
Effects of Rous Sarcoma Virus on the synthetic programs of chondroblasts and retinal melanoblasts. Am J Anat (1976) 0.89
Arrangement of integrated avian sarcoma virus DNA sequences within the cellular genomes of transformed and revertant mammalian cells. J Virol (1980) 0.88
Transformation by Rous sarcoma virus induces similar patterns of glycosaminoglycan synthesis in chick embryo skin fibroblasts and vertebral chondroblasts. J Biol Chem (1983) 0.88
Aggregation of platelets and cell membrane vesiculation by rat cells transformed in vitro by Rous sarcoma virus. Cancer Res (1978) 0.87
Inhibition of chicken embryo lens differentiation and lens junction formation in culture by pp60v-src. Mol Cell Biol (1988) 0.86
The response of chicken embryo dermal fibroblasts to cytochalasin B is altered by Rous sarcoma virus-induced cell transformation. Mol Cell Biol (1982) 0.86
Serum-free growth of normal and transformed fibroblasts in milk: differential requirements for fibronectin. J Cell Biol (1981) 0.86
HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells. Apoptosis (1997) 0.85
Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. AIDS Res Hum Retroviruses (1996) 0.85
Characterization of group specific antibodies in primates: studies with SIV envelope in macaques. J Med Primatol (1992) 0.85
Role of cell division in differentiation of myoblasts infected with a temperature-sensitive mutant of Rous sarcoma virus. EMBO J (1984) 0.85
Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts. J Biol Chem (1982) 0.84
HeLa-LAV, an epithelial cell line stably infected with HIV-1. J Virol Methods (1992) 0.84
Expression of v-src alters the expression of myogenic regulatory factor genes. Oncogene (1994) 0.84
Comparative immunogenicity of gp120-derived proteins and their induction of anti-V3 loop region antibodies. J Acquir Immune Defic Syndr (1992) 0.82
In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures. Am J Clin Pathol (1987) 0.82
Cell fusion for genetic analysis of two nonconditional Rous sarcoma virus replication mutants. J Virol (1979) 0.80
Interaction of oncogenes with differentiation programs. Curr Top Microbiol Immunol (1989) 0.80
The serum-free growth of cultured cells in bovine colostrum and in milk obtained later in the lactation period. J Cell Physiol (1981) 0.80
Maternal monoclonal antibody to the V3 loop alters specificity of the response to a human immunodeficiency virus vaccine. J Infect Dis (1996) 0.80
Epitopes of adhesion-perturbing monoclonal antibodies map within a predicted alpha-helical domain of the integrin beta 1 subunit. J Cell Sci (1997) 0.80
Infection of chick limb bud presumptive chondroblasts by a temperature-sensitive mutant of Rous sarcoma virus and the reversible inhibition of their terminal differentiation in culture. Mol Cell Biol (1983) 0.80
Anti-idiotypic antisera raised against monoclonal antibody specific for a p24 gag region epitope detects a common interspecies idiotype associated with anti-HIV responses. Viral Immunol (1990) 0.80
Envelope assembly mutant of rous sarcoma virus. J Virol (1980) 0.79
Repression of integrin beta 1 subunit expression by antisense RNA. Cell Struct Funct (1991) 0.79
Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual. J Clin Invest (1988) 0.78
Expression of the Rous sarcoma virus src gene in avian macrophages fails to elicit transformed cell phenotype. Mol Cell Biol (1984) 0.78
Collagen synthesis in virus-transformed cells. Ann N Y Acad Sci (1985) 0.78
The effects of temperature-sensitive Rous sarcoma virus and phorbol diester tumor promoters on cell lineages. Results Probl Cell Differ (1980) 0.77
Altered stem cell (CFU-S) function following infection of hematopoietic cells with a virus carrying V-src. Blood (1986) 0.77
Phosphorylation of integrin in differentiating ts-Rous sarcoma virus-infected myogenic cells. Oncogene (1991) 0.77